Published in Photochem Photobiol on January 01, 1991
Scattering of exciting light by live cells in fluorescence confocal imaging: phototoxic effects and relevance for FRAP studies. Biophys J (2007) 1.12
Effects of motion on optical properties in the spatial frequency domain. J Biomed Opt (2011) 0.97
Current and emerging technologies in melanoma diagnosis: the state of the art. Clin Dermatol (2008) 0.96
Wide-field spectral imaging of human ovary autofluorescence and oncologic diagnosis via previously collected probe data. J Biomed Opt (2012) 0.79
Diagnosis of vulvar lesions by non-invasive optical analysis: a pilot study. Rare Tumors (2009) 0.75
Concurrent Reflectance Confocal Microscopy and Laser Doppler Flowmetry to Improve Skin Cancer Imaging: A Monte Carlo Model and Experimental Validation. Sensors (Basel) (2016) 0.75
Preliminary results on the use of a noninvasive instrument for the evaluation of the depth of pigmented skin lesions: numerical simulations and experimental measurements. Lasers Med Sci (2009) 0.75
Prognostic factors analysis of 17,600 melanoma patients: validation of the American Joint Committee on Cancer melanoma staging system. J Clin Oncol (2001) 10.20
Final version of the American Joint Committee on Cancer staging system for cutaneous melanoma. J Clin Oncol (2001) 9.68
Comparing radical mastectomy with quadrantectomy, axillary dissection, and radiotherapy in patients with small cancers of the breast. N Engl J Med (1981) 7.53
Prognostic value of tumor infiltrating lymphocytes in the vertical growth phase of primary cutaneous melanoma. Cancer (1996) 4.46
Inefficacy of immediate node dissection in stage 1 melanoma of the limbs. N Engl J Med (1977) 3.45
Delayed regional lymph node dissection in stage I melanoma of the skin of the lower extremities. Cancer (1982) 2.71
Lack of effect of pregnancy on outcome of melanoma. For The World Health Organisation Melanoma Programme. Lancet (1991) 2.58
Axillary lymph node staging in breast cancer by 2-fluoro-2-deoxy-D-glucose-positron emission tomography: clinical evaluation and alternative management. J Natl Cancer Inst (2001) 2.57
Stage I melanoma of the limbs: assessment of prognosis by levels of invasion and maximum thickness. Tumori (1978) 2.46
Tumor infiltrating lymphocytes in lymph node melanoma metastases: a histopathologic prognostic indicator and an expression of local immune response. Lab Invest (1996) 2.31
Tumor regression responses in melanoma patients treated with a peptide encoded by gene MAGE-3. Int J Cancer (1995) 2.28
Breast cancer patients treated without axillary surgery: clinical implications and biologic analysis. Ann Surg (2000) 2.27
Thin stage I primary cutaneous malignant melanoma. Comparison of excision with margins of 1 or 3 cm. N Engl J Med (1988) 2.15
Presentation and surgical management of bronchogenic and esophageal duplication cysts in adults. Chest (1998) 2.07
Comparison of Halsted mastectomy with quadrantectomy, axillary dissection, and radiotherapy in early breast cancer: long-term results. Eur J Cancer Clin Oncol (1986) 2.05
Which kinds of lymph node metastases can FDG PET detect? A clinical study in melanoma. J Nucl Med (2000) 1.93
Sentinel lymph node biopsy in cutaneous melanoma: the WHO Melanoma Program experience. Ann Surg Oncol (2000) 1.92
Surgical treatment of phyllodes tumors of the breast. Cancer (1989) 1.89
Long-term, totally implantable central venous access ports connected to a Groshong catheter for chemotherapy of solid tumours: experience from 178 cases using a single type of device. Eur J Cancer (1997) 1.84
Results of adjuvant interferon study in WHO melanoma programme. Lancet (1994) 1.62
Prognostic significance of HER-2/neu expression in breast cancer and its relationship to other prognostic factors. Int J Cancer (1991) 1.58
Vimentin and p53 expression on epidermal growth factor receptor-positive, oestrogen receptor-negative breast carcinomas. Br J Cancer (1988) 1.55
Histopathologic diagnosis of dysplastic nevi: concordance among pathologists convened by the World Health Organization Melanoma Programme. Hum Pathol (1991) 1.54
Pathobiologic identification of two distinct breast carcinoma subsets with diverging clinical behaviors. Breast Cancer Res Treat (1999) 1.54
Narrow excision (1-cm margin). A safe procedure for thin cutaneous melanoma. Arch Surg (1991) 1.52
A new American Joint Committee on Cancer staging system for cutaneous melanoma. Cancer (2000) 1.52
Risk of internal mammary lymph node metastases and its relevance on prognosis of breast cancer patients. Ann Surg (1983) 1.50
Clinical diagnosis and therapy of cutaneous melanoma in situ. Cancer (1996) 1.43
Is herpes zoster unilateral? West J Med (1999) 1.39
The AJCC staging proposal for cutaneous melanoma: comments by the EORTC Melanoma Group. Ann Oncol (2001) 1.38
Stage I melanoma of the skin: evaluation of prognosis according to histologic characteristics. Cancer (1981) 1.33
Human polymorphonuclear leukocytes produce and express functional tissue factor upon stimulation. J Thromb Haemost (2006) 1.30
Multicenter phase III randomized trial of polychemotherapy (CVD regimen) versus the same chemotherapy (CT) plus subcutaneous interleukin-2 and interferon-alpha2b in metastatic melanoma. Ann Oncol (2006) 1.29
The structure and function of the helical heart and its buttress wrapping. I. The normal macroscopic structure of the heart. Semin Thorac Cardiovasc Surg (2001) 1.29
Lymphoid infiltration as a prognostic variable for early-onset breast carcinomas. Clin Cancer Res (1997) 1.29
Mucinous carcinoma of the breast. A clinicopathologic, histochemical, and immunocytochemical study with special reference to neuroendocrine differentiation. Am J Surg Pathol (1994) 1.28
The helix-loop-helix protein Id-1 and a retinoblastoma protein binding mutant of SV40 T antigen synergize to reactivate DNA synthesis in senescent human fibroblasts. Dev Genet (1996) 1.27
Prognosis of breast cancer patients after mastectomy and dissection of internal mammary nodes. Ann Surg (1985) 1.27
Prognostic significance of the 67-kilodalton laminin receptor expression in human breast carcinomas. J Natl Cancer Inst (1993) 1.23
Replicative senescence, aging and growth-regulatory transcription factors. Biol Signals (1997) 1.18
Response to cyclophosphamide, methotrexate, and fluorouracil in lymph node-positive breast cancer according to HER2 overexpression and other tumor biologic variables. J Clin Oncol (2001) 1.15
Utility of adjuvant systemic therapy in melanoma. Ann Oncol (2009) 1.10
Functional renal failure and haemorrhagic gastritis associated with endotoxaemia in cirrhosis. Gut (1977) 1.07
A randomized trial of adjuvant chemotherapy and immunotherapy in cutaneous melanoma. N Engl J Med (1982) 1.06
Imaging with 131I-labeled monoclonal antibodies to a high-molecular-weight melanoma-associated antigen in patients with melanoma: efficacy of whole immunoglobulin and its F(ab')2 fragments. Cancer Res (1985) 1.06
Prognosis of malignant melanoma according to regional metastases. Am J Roentgenol Radium Ther Nucl Med (1971) 1.06
A phase I-II study of the histone deacetylase inhibitor valproic acid plus chemoimmunotherapy in patients with advanced melanoma. Br J Cancer (2009) 1.05
Cellular and humoral immunity against human malignant melanoma. Int J Cancer (1971) 1.02
Stage I melanoma of the limbs. Immediate versus delayed node dissection. Tumori (1980) 1.01
Regional non-nodal metastases of cutaneous melanoma. Eur J Surg Oncol (1986) 1.01
Autologous peripheral blood CD133+ cell implantation for limb salvage in patients with critical limb ischemia. Bone Marrow Transplant (2009) 0.99
Intrinsic stability of quantum cascade lasers against optical feedback. Opt Express (2013) 0.98
A laboratory and thrombokinetic study of HCV-associated thrombocytopenia: a direct role of HCV in bone marrow exhaustion? Clin Exp Rheumatol (1996) 0.98
Overexpression of the T-cell receptor beta-chain variable region TCRBV14 in HLA-A2-matched primary human melanomas. Cancer Res (1995) 0.97
Prognosis of breast cancer with axillary node metastases after surgical treatment only. Eur J Cancer Clin Oncol (1987) 0.95
Dysphagia after definitive radiotherapy for head and neck cancer. Correlation of dose-volume parameters of the pharyngeal constrictor muscles. Strahlenther Onkol (2013) 0.95
BANS. A cutaneous region with no prognostic significance in patients with melanoma. Cancer (1986) 0.94
Prognosis based on primary breast carcinoma instead of pathological nodal status. Br J Cancer (1994) 0.93
Extinction and absorption coefficients and scattering phase functions of human tissues in vitro. Appl Opt (1989) 0.92
In vivo activation of lymphocytes in melanoma patients receiving escalating doses of recombinant interleukin 2. Int J Cancer (1988) 0.92
Immunocytochemical identification of breast carcinoma cells in effusions using a monoclonal antibody. J Clin Pathol (1982) 0.91
Treatment patterns and outcomes among patients diagnosed with unresectable stage III or IV melanoma in Europe: a retrospective, longitudinal survey (MELODY study). Eur J Cancer (2012) 0.91
Circulating cytokines and gastrin levels in asymptomatic subjects infected by Helicobacter pylori (H. pylori). Immunopharmacol Immunotoxicol (2001) 0.91
Small sized phyllodes tumor of the breast. Eur J Surg Oncol (1990) 0.90
Prefrontal cortex rTMS enhances action naming in progressive non-fluent aphasia. Eur J Neurol (2012) 0.89
Treatment of primary or relapsing limb cancer by isolation perfusion with high-dose alpha-tumor necrosis factor, gamma-interferon, and melphalan. Cancer (1994) 0.88
Prognosis of skin melanoma with regional node metastases (stage II). J Surg Oncol (1984) 0.88
The structure and function of the helical heart and its buttress wrapping. IV. Concepts of dynamic function from the normal macroscopic helical structure. Semin Thorac Cardiovasc Surg (2001) 0.88
Hepatic intra-arterial versus intravenous fotemustine in patients with liver metastases from uveal melanoma (EORTC 18021): a multicentric randomized trial. Ann Oncol (2014) 0.88
Microprocessor-controlled optical stimulating device to improve the gait of patients with Parkinson's disease. Med Biol Eng Comput (2004) 0.88
Autologous non-myeloablative hematopoietic stem cell transplantation in patients with systemic sclerosis. Bone Marrow Transplant (2007) 0.88
Economic impact of healthcare resource utilisation patterns among patients diagnosed with advanced melanoma in the United Kingdom, Italy, and France: results from a retrospective, longitudinal survey (MELODY study). Eur J Cancer (2012) 0.88
Mucosal malignant melanoma of head and neck: forty-eight cases treated at Istituto Nazionale Tumori of Milan. Eur J Surg Oncol (1993) 0.87
Importance of the level of axillary involvement in relation to traditional variables in the prognosis of breast cancer. Int J Oncol (1999) 0.87
Systemic administration of autologous, alloactivated helper-enriched lymphocytes to patients with metastatic melanoma of the lung. A phase I study. Cancer Immunol Immunother (1986) 0.87
Gastric emptying and orocecal transit time in pregnancy. J Gastroenterol (2001) 0.87
Long-term survival and prognostic factors for 2170 breast cancer patients treated at two cancer centers (Milan and Houston). Tumori (1989) 0.87
Light-induced fluorescence spectroscopy of adenomas, adenocarcinomas and non-neoplastic mucosa in human colon. I. In vitro measurements. J Photochem Photobiol B (1992) 0.87
Pretargeting strategies for radio-immunoguided tumour localisation and therapy. Eur J Cancer (1997) 0.86
Sentinel node localization in primary melanoma: preoperative dynamic lymphoscintigraphy, intraoperative gamma probe, and vital dye guidance. Surgery (2000) 0.86
Sentinel node localization in cutaneous melanoma: lymphoscintigraphy with colloids and antibody fragments versus blue dye mapping. Eur J Nucl Med (1998) 0.86
Phenotypic expression of familial amyloid polyneuropathy in Brazil. Eur J Neurol (2005) 0.86
Early presence of activated ('exhausted') platelets in malignant tumors (breast adenocarcinoma and malignant melanoma). Eur J Cancer Clin Oncol (1989) 0.86
Ex vivo optical properties of human colon tissue. Lasers Surg Med (1994) 0.85
Surgery for malignant mesenchymal tumors of the breast: a series of 31 cases. Tumori (1982) 0.85
15-deoxy-delta12,14-Prostaglandin J2 inhibits tissue factor expression in human macrophages and endothelial cells: evidence for ERK1/2 signaling pathway blockade. Thromb Haemost (2002) 0.85
A possible new tool for clinical diagnosis of melanoma: the computer. J Am Acad Dermatol (1987) 0.85
Reactivity of a monoclonal antibody with tissues and tumors from the human breast. Immunohistochemical localization of a new antigen and clinicopathologic correlations. Am J Pathol (1984) 0.85
Ha-ras-1 restriction fragment length polymorphism and susceptibility to colon adenocarcinoma. Br J Cancer (1987) 0.85
Increasing incidence of cutaneous melanoma, ultraviolet radiation and the clinician. Photochem Photobiol (1989) 0.85
Evaluation of the risk of multiple primaries in malignant cutaneous melanoma. Tumori (1977) 0.84
The cytologic diagnosis of gastric carcinoma related to the histologic type. Acta Cytol (1977) 0.84
Small melanomas: a clinical study on 270 consecutive cases of cutaneous melanoma. Melanoma Res (1999) 0.84
Acral lentiginous melanoma. A histological type without prognostic significance. J Dermatol Surg Oncol (1994) 0.84